Quest Diagnostics (DGX) Stock Forecast & Price Target $169.45 +0.25 (+0.15%) Closing price 04/1/2025 03:59 PM EasternExtended Trading$169.28 -0.17 (-0.10%) As of 04/1/2025 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Quest Diagnostics - Analysts' Recommendations and Stock Price Forecast (2025) How MarketBeat Calculates Price Target and Consensus Rating MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Consensus Rating Moderate BuyBased on 15 Analyst RatingsSell0Hold7Buy8 Based on 15 Wall Street analysts who have issued ratings for Quest Diagnostics in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 15 analysts, 7 have given a hold rating, 6 have given a buy rating, and 2 have given a strong buy rating for DGX. Consensus Price Target $178.385.28% Upside According to the 15 analysts' twelve-month price targets for Quest Diagnostics, the average price target is $178.38. The highest price target for DGX is $191.00, while the lowest price target for DGX is $165.00. The average price target represents a forecasted upside of 5.28% from the current price of $169.45. Get the Latest News and Ratings for DGX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Quest Diagnostics and its competitors. Enter your email to sign up for newsletter Sign Up DGX Analyst Ratings Over TimeTypeCurrent Forecast4/2/24 to 4/2/251 Month Ago3/3/24 to 3/3/253 Months Ago1/3/24 to 1/2/251 Year Ago4/3/23 to 4/2/24Strong Buy2 Strong Buy rating(s)2 Strong Buy rating(s)1 Strong Buy rating(s)0 Strong Buy rating(s)Buy6 Buy rating(s)7 Buy rating(s)6 Buy rating(s)2 Buy rating(s)Hold7 Hold rating(s)6 Hold rating(s)8 Hold rating(s)9 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$178.38$178.23$169.15$144.18Forecasted Upside5.28% Upside0.80% Upside12.05% Upside8.96% UpsideConsensus RatingModerate BuyModerate BuyModerate BuyHold Remove Ads DGX Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History DGX Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Quest Diagnostics Stock vs. The CompetitionTypeQuest DiagnosticsMedical CompaniesS&P 500Consensus Rating Score 2.67 2.82 2.54Consensus RatingModerate BuyModerate BuyModerate BuyPredicted Upside5.28% Upside19,857.29% Upside19.03% UpsideNews Sentiment RatingPositive NewsSee Recent DGX NewsPositive NewsPositive News Remove Ads Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails3/20/2025Robert W. Baird2 of 5 starsEric ColdwellSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetOutperform ➝ Outperform$190.00 ➝ $191.00+14.62%3/4/2025Citigroup3 of 5 starsPatrick DonnellySubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral$185.00 ➝ $185.00+4.63%2/4/2025JPMorgan Chase & Co.3 of 5 starsLisa GillSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetNeutral ➝ Neutral$173.00 ➝ $180.00+9.61%2/3/2025MizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingAnn HynesSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetOutperform ➝ Outperform$177.00 ➝ $178.00+9.56%2/3/2025UBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingKevin CaliendoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetNeutral ➝ Neutral$166.00 ➝ $170.00+5.01%2/3/2025Piper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingDavid WestenbergSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$165.00 ➝ $180.00+11.76%1/31/2025Truist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingDavid MacdonaldSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetHold ➝ Hold$172.00 ➝ $182.00+11.17%1/31/2025BarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingStephanie DavisSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetEqual Weight ➝ Equal Weight$168.00 ➝ $175.00+6.73%1/6/2025Leerink PartnrsSubscribe to MarketBeat All Access for the recommendation accuracy ratingM. ChernySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Strong-Buy1/6/2025Leerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy rating UpgradeMarket Perform ➝ Outperform$169.00 ➝ $174.00+14.53% Get the Latest News and Ratings for DGX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Quest Diagnostics and its competitors with MarketBeat's FREE daily newsletter. 12/17/2024Morgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy rating UpgradeEqual Weight ➝ Overweight$145.00 ➝ $172.00+12.65%12/13/2024Bank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetBuy ➝ Buy$179.00 ➝ $182.00+16.56%12/10/2024Jefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingBuy ➝ Buy$175.00 ➝ $185.00+16.97%10/23/2024Baird R WSubscribe to MarketBeat All Access for the recommendation accuracy ratingE. ColdwellSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Strong-Buy8/28/2024Evercore ISISubscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageIn-Line$165.00+7.38%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 03:38 AM ET. DGX Forecast - Frequently Asked Questions What is Quest Diagnostics' forecast for 2025? According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Quest Diagnostics is $178.38, with a high forecast of $191.00 and a low forecast of $165.00. Should I buy or sell Quest Diagnostics stock right now? 15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Quest Diagnostics in the last year. There are currently 7 hold ratings, 6 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" DGX shares. Does Quest Diagnostics's stock price have much upside? According to analysts, Quest Diagnostics's stock has a predicted upside of 5.28% based on their 12-month stock forecasts. Has Quest Diagnostics been upgraded or downgraded by Wall Street analysts recently? Over the previous 90 days, Quest Diagnostics's stock had 2 upgrades and 1 downgrade by analysts. What analysts cover Quest Diagnostics? Quest Diagnostics has been rated by research analysts at Barclays, Citigroup, JPMorgan Chase & Co., Leerink Partners, Leerink Partnrs, Mizuho, Piper Sandler, Robert W. Baird, Truist Financial, and UBS Group in the past 90 days. Do Wall Street analysts like Quest Diagnostics more than its competitors? Analysts like Quest Diagnostics less than other "medical" companies. The consensus rating score for Quest Diagnostics is 2.67 while the average consensus rating score for "medical" companies is 2.82. Learn more on how DGX compares to other companies. Stock Forecasts and Research Tools Related Companies LH Stock Forecast DVA Stock Forecast CHE Stock Forecast AMED Stock Forecast MD Stock Forecast AMN Stock Forecast CCRN Stock Forecast NTRA Stock Forecast EXAS Stock Forecast GH Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NYSE:DGX) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Tax Shock?Elon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quest Diagnostics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Quest Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DGX Stock Free DGX Stock Alerts